Thromboelastography in Non-elective Cesarean Delivery
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01514591|
Recruitment Status : Completed
First Posted : January 23, 2012
Last Update Posted : June 21, 2013
|Condition or disease|
|Study Type :||Observational|
|Actual Enrollment :||33 participants|
|Official Title:||Thromboelastography to Assess Hemostatic Changes in Laboring Patients Undergoing Non-elective (Intrapartum) Cesarean Delivery|
|Study Start Date :||August 2011|
|Actual Primary Completion Date :||June 2013|
|Actual Study Completion Date :||June 2013|
Non-elective Cesarean Delivery
We will only enroll patients undergoing non-elective CS with an 'epidural top-up' for surgical anesthesia. By definition, our study will only apply to laboring women with working labor epidurals (which were provided for labor analgesia).
- Estimated blood loss; Coagulation data (Thromboelastography, Laboratory) [ Time Frame: pre and post cesarean delivery, an expected average of 75 minutes ]This study will allow us to collect more information about the hemostatic effects that occur during non-elective Cesarean delivery. This information will add to current knowledge base (which we have published) about coagulation changes in the peripartum period in patients undergoing non-elective Cesarean section.
- Hematologic indices [ Time Frame: Pre and post cesarean delivery, an expected average of 75 minutes ]Hematologic indices will include: Hemoglobin concentration and platelet count.
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01514591
|United States, California|
|Lucile Packard Children's Hospital|
|Stanford, California, United States, 94305|
|Principal Investigator:||Alex Butwick, MBBS, FRCA||Stanford University|